CDC Independent Valuation – 31 December 2025
CDC’s valuation increased in the quarter, supported by an additional 40MW of previously announced contracted capacity, the addition of 196MW of built operating capacity, and continued expansion of the build programme.
The 31 December 2025 independent valuation of CDC shows an increase of A$349 million since 30 September 2025, to A$14.0 billion, reflecting the mid-point of the assessed valuation range of A$13.1 billion to A$15.0 billion.
On this basis, Infratil’s 49.72% interest in CDC is valued at A$6,954 million, up A$174 million from A$6,780 million at 30 September 2025.
Further valuation details are included in the attached presentation document.
Enquiries should be directed to:
Brett Jackson
Investor Relations
Email: brett.jackson@infratil.com
Authorised for release by:
Andrew Carroll
Infratil Chief Financial Officer
Related
Infratil Independent Valuation Update - 31 December 2025
Infratil Independent Valuation Update – 31 December 2025 Attached is an update on the independent valuations completed for three of Infratil’s portfolio companies as at 31 December 2025. Using the
Infratil Newsletter - February 2026
Attached is a copy of the latest Infratil Newsletter for investors. It includes commentary on progress at various portfolio companies and confirms completion of the sale process for two previously
Infratil Newsletter-November 2025
Attached is a copy of the latest Infratil Newsletter for investors. It includes commentary on the recent HY26 financial results and the common topics discussed with investors since the results.